Novartis (Group)

https://www.novartis.com

Twitter: @Novartis

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in these areas. In 2015, the Group achieved net sales of USD 49.4 billion, while R&D throughout the Group amounted to approximately USD 8.9 billion (USD 8.7 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 119,000 full-time-equivalent associates. Novartis products are available in more than 180 countries around the world. *

	Start	1996-12-20 merged
	Predecessor	Ciba-Geigy (Group)
	Industry	CHEMICALS
	Person	Narasimhan, Vasant (Vas) (Novartis 201408– Global Head Developm Novartis Pharma before Global Head Developm Vaccines
	Person 2	Reinhardt, Jörg (Novartis 201308– Board Chairman before Bayer 201008– CEO Bayer HealthCare AG before Novartis COO)

	Region	Basel BS
	Country	Switzerland
	City	4002 Basel BS
	Tel	+41-61-324-2200
		Address record changed: 2020-12-02

Basic data	Employees	J: more than 100,0 (2019-12-31)
	Currency	USD
	Annual sales	47,498,000,000 (sales, net, continued operations, consolidated (2019) 2019-12-31)
	Profit	7,147,000,000 (2019-12-31)
	Cash	9,485,000,000 (2017-12-31)

		* Document for ï¿½About Sectionï¿½:

		Record changed: 2022-08-07